Futura Medical plc (FUM) Ordinary GBP0.02

Sell:8.90pBuy:9.26pNo change

Prices delayed by at least 15 minutes
Sell:8.90p
Buy:9.26p
Change:No change
Prices delayed by at least 15 minutes
Sell:8.90p
Buy:9.26p
Change:No change
Prices delayed by at least 15 minutes

Company Information

About this company

Futura Medical plc is a United Kingdom-based pharmaceutical company. The Company is engaged in the development and sale of pharmaceutical and healthcare products. It is focused on developing a portfolio of products based on its transdermal DermaSys technology. The DermaSys is designed to deliver clinically proven medical treatments via the skin. DermaSys platform with penetration and permeation enhancer components tailored for each product to suit the specific therapeutic indication and desired speed of onset and duration of action. Such targeted delivery offers an optimized profile in terms of dose, onset time and duration of effect. The Company's products include MED3000 and TPR100. The Company's lead product, MED3000, is a topical gel formulation treatment for erectile dysfunction (ED) through an evaporative mode of action. The Company has conducted a Phase III study using MED3000 in ED. The Company is also developing CBD100, which is a topical cannabidiol formulation.

Key people

James Henry Barder
Group Chief Executive, Executive Director
Angela Hildreth
Finance Director, Chief Operating Officer, Company Secretary, Executive Director
Ken W James
Executive Director, Head of R&D
Jeffrey Robert Needham
Independent Non-Executive Chairman of the Board
Harmesh Suniara
Non-Executive Director
Roy Davis
Independent Non-Executive Director
Andrew Vaughan Unitt
Senior Non-Executive Independent Director
Click to see more

Key facts

  • EPIC
    FUM
  • Location
    United Kingdom
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    GB0033278473
  • Market cap
    £26.98m
  • Employees
    12
  • Shares in issue
    303.83m
  • Exchange
    London Stock Exchange (LON)
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.